NovaGo Therapeutics Company
NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic properties generated through their Reverse Translational Medicine™ (RTM™) technology platform.
Employee Number:
1-10
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Founded Date:
2015-03-01
Industry:
Cell, Gene & Biologics Therapeutics
Super Industry:
Biopharma & Life Science Tools
Investors:
Kinled Holding, Neurimmune Holding, Pureos Bioventures
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland
Founders:
Martin E. Schwab, Roger Nitsch